Arcalyst Gets FDA Nod as First Therapy for Recurrent Pericarditis Arcalyst Gets FDA Nod as First Therapy for Recurrent Pericarditis

The agent, rilonacept, is already approved to treat a group of rare inherited inflammatory diseases called cryopyrin-associated periodic syndromes.FDA Approvals
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Cardiology News Alert Source Type: news